BioArctic AB (publ) (STO:BIOA.B)
Sweden
· Delayed Price · Currency is SEK 178.20
-1.60 (-0.89%)
May 9, 2025, 5:29 PM CET
BioArctic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 257.35 | 616 | 228.29 | 23.15 | 62.35 | Upgrade
|
| Other Revenue | - | - | 1.14 | 2.52 | 2.86 | Upgrade
|
| Revenue | 257.35 | 616 | 229.43 | 25.66 | 65.21 | Upgrade
|
| Revenue Growth (YoY) | -58.22% | 168.49% | 794.02% | -60.64% | -76.95% | Upgrade
|
| Cost of Revenue | 26.98 | 14.99 | 74.33 | 55.07 | 50.24 | Upgrade
|
| Gross Profit | 230.37 | 601.01 | 155.11 | -29.4 | 14.96 | Upgrade
|
| Selling, General & Admin | 148.84 | 172.18 | 148.67 | 97.35 | 86.35 | Upgrade
|
| Research & Development | 311.15 | 172.14 | - | - | - | Upgrade
|
| Other Operating Expenses | - | -0.27 | -0.25 | -0.01 | -0.08 | Upgrade
|
| Operating Expenses | 459.99 | 344.05 | 163.04 | 110.45 | 97.28 | Upgrade
|
| Operating Income | -229.62 | 256.96 | -7.94 | -139.85 | -82.32 | Upgrade
|
| Interest Expense | - | -0.33 | -0.56 | -0.84 | -0.98 | Upgrade
|
| Interest & Investment Income | 40.85 | 34.23 | 2.54 | - | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.75 | -14.32 | -5.01 | 0.33 | -3.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | -0.05 | -0.19 | -0.15 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | -189.52 | 276.49 | -11.17 | -140.5 | -86.48 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.01 | -0.21 | Upgrade
|
| Pretax Income | -189.52 | 276.49 | -11.17 | -140.51 | -86.69 | Upgrade
|
| Income Tax Expense | -12.44 | 47.24 | 0.01 | -20.72 | -18.17 | Upgrade
|
| Net Income to Company | -177.08 | 229.25 | -11.18 | -119.79 | -68.52 | Upgrade
|
| Net Income | -177.08 | 229.25 | -11.18 | -119.79 | -68.52 | Upgrade
|
| Net Income to Common | -177.08 | 229.25 | -11.18 | -119.79 | -68.52 | Upgrade
|
| Shares Outstanding (Basic) | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 89 | 88 | 89 | 88 | 88 | Upgrade
|
| Shares Change (YoY) | 0.04% | -0.22% | 0.71% | - | - | Upgrade
|
| EPS (Basic) | -2.00 | 2.60 | -0.13 | -1.36 | -0.78 | Upgrade
|
| EPS (Diluted) | -2.00 | 2.59 | -0.13 | -1.36 | -0.78 | Upgrade
|
| Free Cash Flow | -342.97 | 302.25 | -44.38 | -144.84 | -104.81 | Upgrade
|
| Free Cash Flow Per Share | -3.87 | 3.42 | -0.50 | -1.65 | -1.19 | Upgrade
|
| Gross Margin | 89.52% | 97.57% | 67.60% | -114.58% | 22.95% | Upgrade
|
| Operating Margin | -89.22% | 41.71% | -3.46% | -544.96% | -126.24% | Upgrade
|
| Profit Margin | -68.81% | 37.22% | -4.87% | -466.78% | -105.08% | Upgrade
|
| Free Cash Flow Margin | -133.27% | 49.07% | -19.35% | -564.40% | -160.74% | Upgrade
|
| EBITDA | -211.19 | 275.39 | -1.87 | -134.72 | -78.49 | Upgrade
|
| EBITDA Margin | -82.06% | 44.71% | -0.82% | - | -120.37% | Upgrade
|
| D&A For EBITDA | 18.43 | 18.43 | 6.07 | 5.13 | 3.83 | Upgrade
|
| EBIT | -229.62 | 256.96 | -7.94 | -139.85 | -82.32 | Upgrade
|
| EBIT Margin | -89.22% | 41.71% | -3.46% | - | -126.24% | Upgrade
|
| Effective Tax Rate | - | 17.09% | - | - | - | Upgrade
|
| Revenue as Reported | - | - | -228.63 | 26.69 | 65.94 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.